View Filing Data

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	12 Months Ended
Dec. 31, 2009	Dec. 31, 2008
Current assets:
Cash and cash equivalents	$ 148.5	$ 219.7
Accounts receivable, net of allowance for doubtful accounts of $173.1 and $161.0 at December 31, 2009 and 2008, respectively	574.2	631.6
Supplies inventories	90.0	91.0
Prepaid expenses and other	80.1	83.8
Deferred income taxes	42.8	6.7
Total current assets	935.6	1,032.8
Property, plant and equipment, net	500.8	496.4
Goodwill, net	1,897.1	1,772.2
Intangible assets, net	1,342.2	1,222.6
Investments in joint venture partnerships	71.4	72.0
Other assets, net	90.7	73.5
Total assets	4,837.8	4,669.5
Current liabilities:
Accounts payable	183.1	159.7
Accrued expenses and other	275.7	266.4
Noncontrolling interest	142.4	0.0
Short-term borrowings and current portion of long-term debt	417.2	120.8
Total current liabilities	1,018.4	546.9
Long-term debt, less current portion	977.2	1,600.5
Deferred income taxes and other tax liabilities	577.7	522.9
Other liabilities	158.4	189.6
Total liabilities	$ 2,731.7	$ 2,859.9
Commitments and contingent liabilities
Noncontrolling interest	$ 0.0	$ 121.3
Shareholders' equity
Common stock, 105.3 and 108.2 shares outstanding at December 31, 2009 and 2008, respectively	12.5	12.8
Additional paid-in capital	36.7	237.4
Retained earnings	2,927.9	2,384.6
Less common stock held in treasury	(932.5)	(929.8)
Accumulated other comprehensive income (loss)	61.5	(16.7)
Total shareholders' equity	2,106.1	1,688.3
Total liabilities and shareholders' equity	$ 4,837.8	$ 4,669.5

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2009
Notes To Financial Statements [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"1.#160;#160;#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Basis of Financial Statement Presentation:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Laboratory Corporation of America Holdings with its subsidiaries (the #8220;Company#8221;) is the second largest independent clinical laboratory company in the United States based on 2009 net revenues.#160;#160;Through a national network of laboratories, the Company offers a broad range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, the Company has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical research trials./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Since its founding in 1971, the Company has grown into a network of 38 primary laboratories and over 1,500 patient service centers along with a network of branches and STAT laboratories. With over 28,000 employees, the Company processes tests on more than 440,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium and three provinces in Canada. The Company's operating segments are aggregated within one reportable segment based on the way the Company manages its business. The Company's divisions exhibit similar long-term economic characteristics, process similar transactions and provide their testing services to similar classes of customers./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20% and no representation on the investee's board of directors) are accounted for using the cost method. All significant inter-company transactions and accounts have been eliminated. The Company does not have any variable interest entities or special purpose entities whose financial results are not included in the consolidated financi al statements./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The financial statements of the Company's foreign subsidiaries are measured using the local currency as the functional currency.#160;#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.#160;#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the year.#160;#160;Resulting translation adjustments are included in "Accumulated other comprehensive income#8221;./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company evaluated events occurring subsequent to December 31, 2009 for potential recognition or disclosure in the consolidated financial statements through February 24, 2010./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Revenue Recognition:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Sales are recognized on the accrual basis at the time test results are reported, which approximates when services are provided. Services are provided to certain patients covered by various third-party payer programs including various managed care organizations, as well as the Medicare and Medicaid programs.#160;#160;Billings for services under third-party payer programs are included in sales net of allowances for contractual discounts and allowances for differences between the amounts billed and estimated program payment amounts. Adjustments to the estimated payment amounts based on final settlement with the programs are recorded upon settlement as an adjustment to revenue. In 2009, 2008 and 2007, approximately 19.1%, 17.7% and 18.3%, respectively, of the Company's revenues were derivedfont style="DISPLAY: inline; FONT-WEIGHT: bold"#160;/fontdirectly from the Medicare and Medicaid programs. The Company has capitated agreements with certain managed care customers and recognizes related revenue based on a predetermined monthly contractual rate for each member of the managed care plan regardless of the number or cost of services provided by the Company. In 2009, 2008 and 2007, approximately 4% of the Company's revenues were derivedfont style="DISPLAY: inline; FONT-WEIGHT: bold"#160;/fontfrom such capitated agreements./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160; In connection with revenue arrangements with multiple deliverables, revenue is deferred until the Company can reasonably estimate when the performance obligation ceases or becomes inconsequential./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Use of Estimates:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the /fontfont style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"reported amounts of revenues and expenses during the reported periods. Significant estimates include the allowances for doubtful accounts, deferred tax assets, fair values and amortization lives for intangible assets and accruals for self-insurance reserves and pensions. The allowance for doubtful accounts is determined based on historical collections trends, the aging of a ccounts, current economic conditions and regulatory changes. Actual results could differ from those estimates./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"#160;/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Concentration of Credit Risk:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company maintains cash and cash equivalents with various major financial institutions. The total cash balances on deposit that exceeded the balances insured by the F.D.I.C., were approximately $26.7 at December 31, 2009. Cash equivalents at December 31, 2009, totaled $131.0, which includes amounts invested in money market funds, time deposits, municipal, treasury and government funds./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Substantially all of the Company#8217;s accounts receivable are with companies in the health care industry and individuals. However, concentrations of credit risk are limited due to the number of the Company#8217;s clients as well as their dispersion across many different geographic regions./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Accounts receivable balances (gross) from Medicare and Medicaid were $106.4 and $115.7 at December 31, 2009 and 2008, respectively./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Earnings per Share:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Basic earnings per share is computed by dividing net earnings, less preferred stock dividends and accretion, by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the beginning of the period presented. Potentially dilutive common shares result primarily from the Company#8217;s outstanding stock options, restricted stock awards, performance share awards, and shares issuable upon conversion of zero-coupon subordinated notes./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The following represents a reconciliation of basic earnings per share to diluted earnings per share:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd style="PADDING-BOTTOM: 2px" valign="bottom" width="34%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="20%" colspan="10"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160 ;#160;#160;#160;2009/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="20%" colspan="10"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;2008/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="20%" colspan="10"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;2007/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr td valign="bottom" width="34%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160; Per/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160; Per/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160; Per#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr td valign="bottom" width="34%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;Share/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160; Share/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160; Share/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr td style="PADDING-BOTTOM: 2px" valign="bottom" width="34%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2" nowrap="nowrap"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Income/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Shares/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Amount/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Income/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Shares/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Amount/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Income/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="5%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Shares/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Amount/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="34%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"/font#160;/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="5%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="#cceeff" td style="PADDING-BOTTOM: 4px" valign="bottom" width="34%"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Basic earnings per share/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"543.3/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"107.4/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDE R-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"5.06/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"464.5/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"109.7/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inli ne; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"4.23/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT - -SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"476.8/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right; PAD DING-BOTTOM: 4px" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"116.8/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"4.08/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign= "bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="34%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;Stock options/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"0.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"0.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"1.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="34%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;Restricted stock awards and other/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"0.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"0.3/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"0.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="white" td style="PADDING-BOTTOM: 2px" valign="bottom" width="34%"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;Effect of convertible debt, net of tax/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"1.0/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" lt;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FA MILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMIL Y: times new roman; FONT-SIZE: 9pt"1.1/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt" mp;#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"2.5/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right; PAD DING-BOTTOM: 2px" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="#cceeff" td style="PADDING-BOTTOM: 4px" valign="bottom" width="34%"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Diluted earnings per share/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"543.3/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style= "DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"109.1/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMIL Y: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"4.98/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"464.5/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new r oman; FONT-SIZE: 9pt"111.8/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"4.16/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FON T-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"476.8/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font t;/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="4%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"121.3/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/ tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"3.93/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="34%" colspan="10"div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Years Ended December 31,/font/div/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="2"div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2009/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="2"div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2008/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="2"div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2007/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="64%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -35.8pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Stock options/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"4.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"1.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Stock Compensation Plans:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock awards and performance shares is determined based on the number of shares granted and the quoted price of the Company#8217;s common stock. Such value is recognized as expense over the /fontfont style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"service period, net of estimated forfeitures. The estimation of equity awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from the Company#8217;s current estimates, such amounts will be recorded as a cumulat ive adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Actual results and future estimates may differ substantially from the Company#8217;s current estimates./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The following table summarizes the components of the Company#8217;s stock-based compensation expense for the years ended December 31, 2009, 2008, and 2007:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="22%" colspan="10"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160 ;#160;#160;#160;#160;#160; 2009/font/div/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="22%" colspan="10"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160; ;#160;#160;#160;2008/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="22%" colspan="10"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;#160;2007/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr td valign="bottom" width="28%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Pre-tax/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160; Tax/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Pre-tax/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160; Tax/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;Pre-tax/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2" div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; #160; Tax/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Expense/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;Benefit/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160; Net/font/div/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td t;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Expense/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;Benefit/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160;#160;Net/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Expense/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; Benefit/font/div/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="botto m" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="6%" colspan="2"div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160;#160;#160;#160;#160; Net/font/div/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="28%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"/font#160;/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td valign="bottom" width="6%" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="28%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Stock option and stock purchase plans/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"21.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(8.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"13.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"20.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(8.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"12.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"18.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(7.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"10.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="28%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Restricted stock and/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="28%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;#160; performance share awards/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"14.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(5.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"8.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"14.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(5.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"8.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"17.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(7.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"10.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="#cceeff" td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Executive retirement charge/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font s tyle="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMIL Y: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: t imes new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"2.0/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: tim es new roman; FONT-SIZE: 9pt"(0.8/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"1.2/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160; ;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/fo nt/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"--/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr tr bgcolor="white" td style="PADDING-BOTTOM: 4px" valign="bottom" width="28%"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -22.3pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"Total share based compensation/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"36.4/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font sty le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(14.6/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new ro man; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"21.8/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FON T-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"36.2/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt" (14.5/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"21.7/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/fon t/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"35.4/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-B OTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"(14.2/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt")/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="5%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"21.2/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 9pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During the fourth quarter of 2008, the Company recorded charges of approximately $2.0, related to the acceleration of the recognition of stock compensation due to the retirement of the Company#8217;s Executive Vice President of Corporate Affairs, effective December 31, 2008./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;See note 14 for assumptions used in calculating compensation expense for the Company#8217;s stock compensation plans./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Cash Equivalents:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Cash equivalents (primarily investments in money market funds, time deposits, municipal, treasury and government funds which have original maturities of three months or less at the date of purchase) are carried at cost which approximates market./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Inventories:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Inventories, consisting primarily of purchased laboratory supplies, are stated at the lower of cost (first-in, first-out) or market./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Property, Plant and Equipment:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Property, plant and equipment are recorded at cost. The cost of properties held under capital leases is equal to the lower of the net present value of the minimum lease payments or the fair value of the leased property at the inception of the lease. Depreciation and amortization expense is computed on all classes of assets based on their estimated useful lives, as indicated below, using principally the straight-line method./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Years/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="88%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Buildings and building improvements/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"35/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="88%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Machinery and equipment/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"3-10/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="88%" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Furniture and fixtures/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"5-10/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Leasehold improvements and assets held under capital leases are amortized over the shorter of their estimated useful lives or the term of the related leases. Expenditures for repairs and maintenance are charged to operations as incurred. Retirements, sales and other disposals of assets are recorded by removing the cost and accumulated depreciation from the related accounts with any resulting gain or loss reflected in the consolidated statements of operations./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"#160;/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Capitalized Software Costs:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company capitalizes purchased software which is ready for service and capitalizes software development costs incurred on significant projects starting from the time that the preliminary project stage is completed and management commits to funding a project until the project is substantially complete and the software is ready for its intended use. Capitalized costs include direct material and service costs and payroll and payroll-related costs. Research and development costs and other computer software maintenance costs related to software development are expensed as incurred. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the underlying system, generally five years./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Long-Lived Assets:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Goodwill is evaluated for impairment by applying a fair value based test on an annual basis and more frequently if events or changes in circumstances indicate that the asset might be impaired./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Long-lived assets, other than goodwill, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. Recoverability of assets to be held and used is determined by the Company at the level for which there are identifiable cash flows by comparison of the carrying amount of the assets to future undiscounted net cash flows before interest expense and income taxes expected to be generated by the assets. Impairment, if any, is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets (based on market prices in an active market or on discounted cash flows). Assets to be disposed of are reported at the lower of the carrying amount or fair value./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company completed an annual impairment analysis of its indefinite lived assets, including goodwill, and has found no instances of impairment as of December 31, 2009./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Intangible Assets:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Intangible assets (patents and technology, customer relationships and non-compete agreements), are amortized on a straight-line basis over the expected periods to be benefited, such as legal life for patents and technology, 10 to 25 years for customer lists and contractual lives for non-compete agreements./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Debt Issuance Costs:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The costs related to the issuance of debt are capitalized and amortized to interest expense using the effective interest method over the terms of the related debt./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Professional Liability:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company is self-insured (up to certain limits)#160;for professional liability claims arising in the normal course of business, generally related to the testing and reporting of laboratory test results. The Company estimates a liability that represents the ultimate exposure for aggregate losses below those limits. The liability is discounted and is based on a number of assumptions and factors for known and incurred but not reported claims based on actuarial assessment of the accrual driven by frequency and amount of claims./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Income Taxes:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company accounts for income taxes utilizing the asset and liability method. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for tax loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company does not recognize a tax benefit, unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position.#160;#160;If the recognition threshold is met, the Company recognizes a tax benefit measured at the largest amount of the tax benefit that the Company believes is greater than 50% likely to be realized. The Company records interest and penalties in income tax expense./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"#160;/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Derivative Financial Instruments:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Interest rate swap agreements, which are currently being used by the Company in the management of interest rate exposure, are accounted for at fair value. The Company#8217;s zero-coupon subordinated notes contain two features that are considered to be embedded derivative instruments under authoritative guidance in connection with accounting for derivative instruments and hedging activities. The Company believes these embedded derivatives had no fair value at December 31, 2009 and 2008./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;See note 18 for the Company#8217;s objectives in using derivative instruments and the effect of derivative instruments and related hedged items on the Company#8217;s financial position, financial performance and cash flows./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Fair Value of Financial Instruments:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the zero-coupon subordinated notes, based on market pricing, was approximately $374.6 and $650.7 as of December 31, 2009 and 2008, respectively. The fair market value of the senior notes, based on market pricing, was approximately $645.2 and $539.7 as of December 31, 2009 and 2008, respectively. As of December 31, 2009 and 2008, the estimated fair market value of the Company#8217;s variable rate debt of $486.4 and $491.1, respectively, was estimated by calculating the net present value of related cash flows, discounted at current m arket rates./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Effective January 1, 2008, the Company adopted authoritative guidance in connection with fair value measurements for financial assets and liabilities. The guidance clarifies the definition of fair value, prescribes methods for measuring fair value, establishes a fair value hierarchy based on the inputs used to measure fair value, and expands disclosures about fair value measurements. The three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"font style="MARGIN-LEFT: 36pt" id="TAB1"/fontfont style="DISPLAY: inline; FONT-WEIGHT: bold"Level 1/font #8211; Valuations based on quoted prices for identical assets and liabilities in active markets./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"font style="DISPLAY: inline; FONT-WEIGHT: bold"Level 2/font #8211; Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"font style="DISPLAY: inline; FONT-WEIGHT: bold"Level 3/font #8211; Valuations based on unobservable inputs reflecting the Company#8217;s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During 2009, the Company implemented authoritative guidance for its nonfinancial assets and liabilities that are remeasured at fair value on a non-recurring basis. The adoption of the guidance did not impact the Company#8217;s financial position or results of operations; however, it could have an impact in future periods. In addition, the Company may have additional disclosure requirements in the event the Company completes a significant acquisition or incurs impairment of the Company#8217;s assets in future periods./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"Research and Development:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Company expenses research and development costs as incurred./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"New Accounting Pronouncements:/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In June 2009, the FASB established authoritative United States generally accepted accounting principles (#8220;GAAP#8221;), codifying and superseding all pre-existing accounting standards and literature. This newly codified GAAP is effective for financial statements issued for interim and annual periods ending after September 15, 2009. The Company has adopted the guidance without any impact on the consolidated financial statements./fontbr //div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In December 2007, the FASB issued authoritative guidance requiring all entities to report noncontrolling (minority) interests in subsidiaries as equity in the consolidated financial statements. The Company adopted the guidance as of January 1, 2009 and pursuant to the provisions of the literature, the presentation and disclosure requirements have been applied retrospectively for all periods presented. Due to the nature of the noncontrolling interest put, the Company has not included the noncontrolling interest in its Ontario joint venture in the equity section of the accompanying consolidated balance sheets./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In December 2007, the FASB issued authoritative guidance in connection with business combinations which was intended to simplify existing guidance and converge rulemaking under U.S. GAAP with international accounting rules. The guidance applies prospectively to business combinations where the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. The Company adopted the literature as of January 1, 2009, and the Company began recording acquisitions in accordance with the authoritative guidance. As a result, acquisition related costs, primarily legal and other professional services, of $7.7 were included in selling, general and administrative expenses for the year ended December 31, 2009./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In April 2009, the FASB issued authoritative guidance in connection with accounting for assets acquired and liabilities assumed in a business combination that arise from contingencies. The guidance addresses application issues regarding the initial recognition and measurement, subsequent measurement and accounting, and disclosure of assets and liabilities arising from contingencies in a business combination. Due to the fact that the literature is applicable to acquisitions completed after January 1, 2009 and the Company did not have any business combinations with assets and liabilities arising from contingencies in 2009, the adoption of the authoritative guidance did not impact the Company#8217;s consolidated financial statements./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In May 2008, the FASB issued authoritative guidance in connection with accounting for convertible debt instruments that may be settled in cash upon conversion. The guidance requires that the liability and equity components of convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) be separately accounted for in a manner that reflects an issuer#8217;s nonconvertible debt borrowing rate. The resulting debt discount is amortized over the period the convertible debt is expected to be outstanding as additional non-cash interest expense. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2008, and interim periods within those fiscal years. Retrospective application to all periods presented is required except for instruments that were not outstanding during any of the periods that will be presented in the annual financial statements for the period of adoption but were outstanding during an earlier period. The literature impacts the Company#8217;s zero-coupon subordinated notes, and requires that additional interest expense essentially equivalent to the portion of issuance proceeds retroactively allocated to the instrument#8217;s equity component be recognized over the period from the zero-coupon subordinated notes#8217; issuance in 2001 through September 2004 (the first date holders of these notes had the ability to put them back to the Company). As anticipated, the adoption of this authoritative guidance and its retrospective application did not have an impact on results of operations for periods following 2004, but it did result in an increase of $215.4 in opening additional paid-in capital and a corresponding decrease in opening retained earnings as of Janua ry 1, 2007, net of deferred tax impacts, on post-2004 consolidated balance sheets./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In December 2008, the FASB issued authoritative guidance in connection with employers#8217; disclosures about postretirement benefit plan assets. The objectives of the disclosures about plan assets in an employers#8217; defined benefit pension or other postretirement plan are to provide users of financial statements with an understanding of: (1) how investment allocation decisions are made, including the factors that are pertinent to an understanding of investment policies and strategies, (2) the major categories of plan assets, (3) the inputs and valuation techniques used to measure the fair value of plan assets, (4) the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets for the period, and (5) significant c oncentrations of risk within plan assets. The guidance is effective for years ending after December 15, 2009. Upon initial application, the provisions of the literature are not required for earlier periods that are presented for comparative periods.font style="DISPLAY: inline; FONT-SIZE: 10pt"#160;/fontThe Company is providing the additional disclosures in accordance with the authoritative guidance (see Note 16 to the notes to consolidated financial statements)./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In April 2009, the FASB issued authoritative guidance in connection with determining fair value when the volume and level of activity for an asset or liability have significantly decreased and identifying transactions that are not orderly. The literature provides authoritative guidance in determining whether a market is active or inactive, and whether a transaction is distressed. The guidance is applicable to all assets and liabilities (i.e. financial and nonfinancial) and requires enhanced disclosures, including interim and annual disclosure of the input and valuation techniques (or changes in techniques) used to measure fair value and the defining of the major security types comprising debt and equity securities held based upon the nature and risk of the security. The lite rature is effective for interim and annual periods ending after June 15, 2009. The adoption of the authoritative guidance did not have a material impact on the Company#8217;s consolidated financial statements and related disclosures in the notes thereto./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In May 2009, the FASB issued authoritative guidance related to the accounting for and disclosure of subsequent events, which is effective for interim and annual periods ending after June 15, 2009. This new guidance establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. This guidance introduces new terminology but is based on the same principles that previously existed in the auditing standards. Under this new guidance, the Company is required to provide disclosure of the date through which it has evaluated subsequent events and whether that date represents the date the financial statements were issued or the date the financial statements were av ailable to be issued. For the financial statements related to the years ended December 31, 2009, 2008 and 2007 contained herein, the Company has evaluated subsequent events through February 24, 2010 representing the date these financial statements were issued./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In June 2009, the FASB issued authoritative guidance in connection with adding qualified special purpose entities into the scope of guidance for consolidation of variable interest entities. This literature also modifies the analysis by which a controlling interest of a variable interest entity is determined thereby requiring the controlling interest to consolidate the variable interest entity. A controlling interest exists if a party to a variable interest entity has both (i) the power to direct the activities of a variable interest entity that most significantly impact the entity#8217;s economic performance and (ii) the obligation to absorb losses of or receive benefits from the entity that could be potentially significant to the variable interest entity. The guidance becomes effective as of the beginning of the first annual reporting period beginning after November 15, 2009 and should be applied prospectively for interim and annual periods during that period going forward. The Company is currently evaluating the impact the adoption of the authoritative guidance could have on its consolidated financial statements./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In August 2009, the FASB issued authoritative guidance in connection with measuring liabilities at fair value. The guidance addresses the impact of transfer restrictions on the fair value of a liability and the ability to use the fair value of a liability that is traded as an asset as an input to the valuation of the underlying liability. The literature also clarifies the application of certain valuation techniques. Those clarifications include when to make adjustments to fair value. The guidance became effective in the Company#8217;s quarter ended December 31, 2009. The adoption of the authoritative guidance did not have an impact on the Company#8217;s consolidated financial statements as of and for the year ended December 31, 2009./font/div

11. DEBT

12 Months Ended

Dec. 31, 2009

Notes To Financial Statements [Abstract]

DEBT

11. DEBT

Short-term borrowings and current portion of long-term debt at December 31, 2009 and 2008 consisted of the following:

	December 31,		December 31,
	2009		2008
Zero-coupon convertible subordinated notes	$	292.2	$	--
Term loan, current		50.0		50.0
Revolving credit facility		75.0	;/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"70.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total short-term borrowings and current portion of long-term debt/font/div /td td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"417.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style= "BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"120.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Long-term debt at December 31, 2009 and 2008 consisted of the following:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td align="left" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/div /td td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLA Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31,/font/div /td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31,/font/div /td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td align="left" valign="bottom" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/div /td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign ="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#cceeff" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Senior notes due 2013/font/div /td td align="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"351.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left" ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"351.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Senior notes due 2015/font/div /td td align="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"250.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td al ign="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"250.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#cceeff" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10 pt; FONT-FAMILY: times new roman"Term loan, non-current/font/div /td td align="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"375.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"425.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Zero-coupon convertible subordinated notes/font/div /td gt; td align="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left" font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"573.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#cceeff" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Other long-term debt/font/div /td td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"fon t style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom " width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total long-term debt/font/div /td td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"977.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; F ONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1,600.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"#160;/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Credit Facilities/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;On October 26, 2007, the Company entered into senior unsecured credit facilities with Credit Suisse, acting as Administrative Agent, and a group of financial institutions totaling $1,000.0. The credit facilities consist of a five-year Revolving Facility in the principal amount of $500.0 and a five-year, $500.0 Term Loan Facility. The balances outstanding on the Company#8217;s Term Loan Facility at December 31, 2009 and 2008 were $425.0 and $475.0, respectively. The balances outstanding on the Company#8217;s Revolving Facility at December 31, 2009 and 2008 were $75.0 and $70.8, respectively. The senior unsecured credit facilities bear interest at varying rates based upon LIBOR plus a percentage based on the Company#8217;s credit rating with Standard amp; Poor's Ratings Services. The remaining quarterly principal repayments of the Term Loan Facility range from $12.5 to $18.8 from March 31, 2010 to September 30, 2012 with $243.8 due on the maturity date of October 26, 2012. At December 31, 2009, future principal repayments under the Term Loan facility are as follows: 2010 - $50.0, 2011 - $75.0 and 2012 - $300.0./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The senior credit facilities are available for general corporate purposes, includi ng working capital, capital expenditures, acquisitions, funding of share repurchases and other payments. The agreement contains certain debt covenants which require that the Company maintain a#160;leverage ratio of no more than 2.5 to 1.0#160;and an#160;interest coverage ratio of at least#160;5.0 to 1.0. Both ratios are calculated in relation to EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization).#160;The credit agreement allows payment of dividends provided that the Company is not in default (as defined in the agreement) and its leverage ratio is#160;less than 2.0 to 1.0.#160;The Company is in compliance with all covenants at December 31, 2009./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" mp;#160;#160;#160;#160;#160;On September 15, 2008, Lehman Brothers Holdings, Inc. (#8220;Lehman#8221;), whose subsidiaries had a $28.0 commitment in the Company#8217;s Revolving Facility, filed for bankruptcy. During the fourth quarter of 2009, another bank assumed Lehman#8217;s commitment in the Company#8217;s Revolving Facility./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;On March 31, 2008, the Company entered into a three-year interest rate swap agreement to hedge variable interest rate risk on the Company#8217;s variable interest rate term loan. Under the swap the Company will, on a quarterly basis, pay a fixed rate of interest (2.92%) and recei ve a variable rate of interest based on the three-month LIBOR rate on an amortizing notional amount of indebtedness equivalent to the term loan balance outstanding. The swap has been designated as a cash flow hedge. Accordingly, the Company recognizes the fair value of the swap in the consolidated balance sheet and any changes in the fair value are recorded as adjustments to accumulated other comprehensive income, net of tax. The fair value of the interest rate swap agreement is the estimated amount that the Company would pay or receive to terminate the swap agreement at the reporting date. The fair value of the swap was a liability of $10.6 and $13.5 at December 31, 2009 and 2008, respectively, and is included in other liabilities in the consolidated balance sheets./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style=" DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;As of December 31, 2009, the effective interest rates on the Term Loan Facility and Revolving Facility were 3.67% and 0.58%, respectively./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Zero-Coupon Convertible Subordinated Notes/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company had $368.8 and $738.3 aggregate pri ncipal amount at maturity of zero-coupon convertible subordinated notes (the #8220;notes#8221;) due 2021 outstanding at December 31, 2009 and 2008, respectively. The notes, which are subordinate to the Company#8217;s bank debt, were sold at an issue price of $671.65 per $1,000 principal amount at maturity (representing a yield to maturity of 2.0% per year). Each one thousand dollar principal amount at maturity of the notes is convertible into 13.4108 shares of the Company#8217;s common stock, subject to adjustment in certain circumstances, if one of the following conditions occurs:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="top" width="3%" div style="MARGIN-LEFT: 0pt; TEXT-IN DENT: 0pt"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1)/fontfont id="TAB2_0" style="COLOR: black; LETTER-SPACING: 9pt"#160;/font/div /td td valign="top" width="74%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"If the sales price of the Company#8217;s common stock for at least 20 trading days in a period of 30 consecutive trading days ending on the last trading day of the preceding quarter reaches specified thresholds (beginning at 120% and declining 0.1282% per quarter until it reaches approximately 110% for the quarter beginning July 1, 2021 of the accreted conversion price per share of common stock on the last day of the preceding quarter). The accreted conversion price per share will equal the issue price of a note plus the accrued original issue discount and any accrued contingent additional principal, divided by the number of shares of common stock issuable upon conversion of a note on that day. The conversion trigger price for the fourth quarter of 2009 was $68.21./font/div /td /tr/table /div div table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="top" width="3%" div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2)/fontfont id="TAB2_1" style="COLOR: black; LETTER-SPACING: 9pt"#160;/font/div /td td valign="top" width="74%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0p t; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"If the credit rating assigned to the notes by Standard amp; Poor#8217;s Ratings Services is at or below#160;#160;BB-./font/div /td /trtr td valign="top" width="3%" div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3)/fontfont id="TAB2_2" style="COLOR: black; LETTER-SPACING: 9pt"#160;/font/div /td td valign="top" width="74%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"If the notes are called for redemption./font/div /td /trtr td valign="top" width="3%" div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"4)/fontfont id="TAB2_3" style="COLOR: black; LETTER-SPACING: 9pt"#160;/font/div /td td valign="top" width="74%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"If specified corporate transactions have occurred (such as if the Company is party to a#160;#160;consolidation, merger or binding share exchange or a transfer of all or substantially all of its assets)./font/div /td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div t; div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Holders of the notes may require the Company to purchase in cash all or a portion of their notes on September 11, 2011 at $819.54 per note, plus any accrued contingent additional principal and any accrued contingent interest thereon./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company may redeem for cash all or a portion of the notes at any time on or after September 11, 2006 at specified redemption prices per one thousand dollar principal amount at mat urity of the notes./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company has registered the notes and the shares of common stock issuable upon conversion of the notes with the Securities and Exchange Commission./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;During the second quarter of 2009, the Company redeemed approximately $369.5 principal amount at maturity of its zero-coupon subordinated notes , equaling approximately#160;50% of the principal amount at maturity outstanding of the zero-coupon subordinated notes. The total cash used for these redemptions was $289.4. As a result of certain holders of the zero-coupon subordinated notes electing to convert their notes, the Company also issued 0.4 additional shares of common stock and reversed approximately $11.3 of deferred tax liability to reflect the tax benefit realized upon issuance of these shares./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company#8217;s common stock trading price contingent cash interest feature of its zero-coupon subordinated notes was not triggered by the average market price of the Company#8217; s common stock for the five trading days ended September 9, 2009. As a result, the zero-coupon subordinated notes will not accrue contingent cash interest for the period of September 12, 2009 to March 11, 2010./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;On January 5, 2010, the Company announced that its zero-coupon subordinated notes may be converted into cash and common stock at the conversion rate of 13.4108 per $1,000 principal amount at maturity of the notes, subject to the terms of the zero-coupon subordinated notes and the Indenture, dated as of October 24, 2006 between the Company and The Bank of New York Mellon, as trustee and conversion agent. In order to exercise the option to convert al l or a portion of the zero-coupon subordinated notes, holders are required to validly surrender their zero-coupon subordinated notes at any time during the calendar quarter beginning January 1, 2010, through the close of business on the lastfont style="DISPLAY: inline; FONT-SIZE: 10pt"#160;/fontbusiness day of the calendar quarter, which is 5:00 p.m., New York City time, on Wednesday, March 31, 2010./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Senior Notes/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-S IZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Senior Notes due January 31, 2013 bear interest at the rate of 5 1/2% per annum from February 1, 2003, payable semi-annually on February 1 and August 1. The Senior Notes due 2015 bear interest at the rate of 5 5/8% per annum from December 14, 2005, payable semi-annually on June 15 and December 15./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2007
Income Statement [Abstract]
Net sales	$ 4,694.7	$ 4,505.2	$ 4,068.2
Cost of sales	2,723.8	2,631.4	2,377.0
Gross profit	1,970.9	1,873.8	1,691.2
Selling, general and administrative expenses	958.9	935.1	808.7
Amortization of intangibles and other assets	62.6	57.9	54.9
Restructuring and other special charges	13.5	37.9	50.6
Operating income	935.9	842.9	777.0
Other income (expenses):
Interest expense	(62.9)	(72.0)	(56.6)
Income from joint venture partnerships, net	13.8	14.4	77.9
Investment income	1.6	2.5	5.4
Other, net	(3.8)	(2.1)	(1.4)
Earnings before income taxes	884.6	785.7	802.3
Provision for income taxes	329.0	307.9	325.5
Net earnings	555.6	477.8	476.8
Less: Net earnings attributable to the noncontrolling interest	(12.3)	(13.3)	0.0
Net earnings attributable to Laboratory Corporation of America Holdings	$ 543.3	$ 464.5	$ 476.8
Basic earnings per common share (in dollars per share)	$ 5.06	$ 4.23	$ 4.08
Diluted earnings per common share (in dollars per share)	$ 4.98	$ 4.16	$ 3.93

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2007
Statement [Line Items]
BALANCE	$ 1,688.3	$ 1,725.3	$ 1,977.1
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	543.3	464.5	476.8
Other comprehensive earnings:
Foreign currency translation adjustments	93.3	(129.6)	96.9
Net benefit plan adjustments	31.5	(81.0)	4.0
Interest rate swap adjustments	2.9	(13.5)
Tax effect of other comprehensive earnings adjustments	(49.5)	87.4	(39.6)
Comprehensive earnings	621.5	327.8	538.1
Issuance of common stock under employee stock plans	24.8	64.4	77.6
Surrender of restricted stock awards	(2.7)	(32.7)	(5.5)
Adoption of authoritative guidance in connection with uncertain tax positions			(0.5)
Conversion of zero-coupon convertible debt	11.4	0.1	0.7
Stock compensation	36.4	36.2	35.4
Value of noncontrolling interest put		(123.0)
Income tax benefit from stock options exercised	(0.1)	20.8	26.6
Purchase of common stock	(273.5)	(330.6)	(924.2)
BALANCE	2,106.1	1,688.3	1,725.3
Common Stock
Statement [Line Items]
BALANCE	12.8	13.2	14.4
Other comprehensive earnings:
Issuance of common stock under employee stock plans		0.1	0.1
Conversion of zero-coupon convertible debt	0.1
Purchase of common stock	(0.4)	(0.5)	(1.3)
BALANCE	12.5	12.8	13.2
Additional Paid-in Capital
Statement [Line Items]
BALANCE	237.4	460.9	1,027.7
Other comprehensive earnings:
Issuance of common stock under employee stock plans	24.8	64.3	77.5
Adoption of authoritative guidance in connection with convertible debt instruments that may be settled in cash upon conversion			215.4
Adoption of authoritative guidance in connection with uncertain tax positions			0.5
Conversion of zero-coupon convertible debt	11.3	0.1	0.7
Stock compensation	36.4	36.2	35.4
Value of noncontrolling interest put		(123.0)
Income tax benefit from stock options exercised	(0.1)	20.8	26.6
Purchase of common stock	(273.1)	(221.9)	(922.9)
BALANCE	36.7	237.4	460.9
Retained Earnings
Statement [Line Items]
BALANCE	2,384.6	2,028.3	1,767.9
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	543.3	464.5	476.8
Other comprehensive earnings:
Adoption of authoritative guidance in connection with convertible debt instruments that may be settled in cash upon conversion			(215.4)
Adoption of authoritative guidance in connection with uncertain tax positions			(1.0)
Purchase of common stock		(108.2)
BALANCE	2,927.9	2,384.6	2,028.3
Treasury Stock
Statement [Line Items]
BALANCE	(929.8)	(897.1)	(891.6)
Other comprehensive earnings:
Surrender of restricted stock awards	(2.7)	(32.7)	(5.5)
BALANCE	(932.5)	(929.8)	(897.1)
Accumulated Other Comprehensive (Loss) Income
Statement [Line Items]
BALANCE	(16.7)	120.0	58.7
Other comprehensive earnings:
Foreign currency translation adjustments	93.3	(129.6)	96.9
Net benefit plan adjustments	31.5	(81.0)	4.0
Interest rate swap adjustments	2.9	(13.5)
Tax effect of other comprehensive earnings adjustments	(49.5)	87.4	(39.6)
Comprehensive earnings	0.0	0.0	0.0
BALANCE	$ 61.5	$ (16.7)	$ 120.0

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2007
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 555.6	$ 477.8	$ 476.8
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	195.1	179.7	162.8
Stock compensation	36.4	36.2	35.4
Loss on sale of assets	2.6	1.1	0.2
Accreted interest on zero-coupon subordinated notes	8.3	11.3	11.1
Cumulative earnings less than (in excess of) distribution from joint venture partnerships	2.2	(0.6)	(8.6)
Deferred income taxes	9.6	69.6	26.5
Change in assets and liabilities (net of effects of acquisitions):
(Increase) decrease in accounts receivable (net)	74.0	28.0	(78.7)
(Increase) decrease in inventories	(4.3)	(8.6)	4.8
(Increase) decrease in prepaid expenses and other	5.9	(15.1)	(16.3)
Increase in accounts payable	22.8	15.9	33.9
Increase (decrease) in accrued expenses and other	(45.8)	(14.4)	61.8
Net cash provided by operating activities	862.4	780.9	709.7
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(114.7)	(156.7)	(142.6)
Proceeds from sale of assets	0.9	0.5	1.4
Deferred payments on acquisitions	(3.3)	(4.1)	(2.8)
Purchases of short-term investments	0.0	(72.8)	(1,777.9)
Proceeds from sale of short-term investments	0.0	182.7	1,803.4
Acquisition of licensing technology	0.0	(0.8)	(0.7)
Investment in equity affiliate	(4.3)	0.0	0.0
Acquisition of businesses, net of cash acquired	(212.6)	(344.8)	(222.3)
Net cash used for investing activities	(334.0)	(396.0)	(341.5)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from term loan	0.0	0.0	500.0
Proceeds from revolving credit facilities	4.2	145.2	240.0
Payments on revolving credit facilities	0.0	(74.4)	(240.0)
Principal payments on term loan	(50.0)	(25.0)	0.0
Payments on zero-coupon subordinated notes	(289.4)	(2.1)	0.0
Payments on vendor-financed equipment	(1.5)	0.0	0.0
Increase (decrease) in bank overdraft	(5.0)	5.0	(34.9)
Payments on long-term debt	(0.1)	(0.1)	(0.1)
Payment of debt issuance costs	(0.1)	(0.1)	(5.8)
Noncontrolling interest distributions	(11.3)	(14.0)	0.0
Excess tax benefits from stock based compensation	0.5	16.2	20.7
Net proceeds from issuance of stock to employees	24.8	64.4	77.6
Purchase of common stock	(273.0)	(333.6)	(921.2)
Net cash used for financing activities	(600.9)	(218.5)	(363.7)
Effect of exchange rate changes on cash and cash equivalents	1.3	(3.1)	0.4
Net increase (decrease) in cash and cash equivalents	(71.2)	163.3	4.9
Cash and cash equivalents at beginning of period	219.7	56.4	51.5
Cash and cash equivalents at end of period	$ 148.5	$ 219.7	$ 56.4

2. BUSINESS ACQUISITIONS	12 Months Ended
2. BUSINESS ACQUISITIONS	Dec. 31, 2009
Notes To Financial Statements [Abstract]
BUSINESS ACQUISITIONS	div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"2.#160;#160;#160;BUSINESS ACQUISITIONS/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During the year ended December 31 2009, the Company acquired various laboratories and related assets for approximately $212.6 in cash (net of cash acquired). The acquisition activity primarily included the acquisition of Monogram Biosciences, Inc. (#8220;Monogram#8221;) effective August 3, 2009 for approximately $160.0 in cash (net of cash acquired). The Monogram acquisition was made to enhance the Company#8217;s scientific differentiation and esoteric testing capabilities and advance the Company#8217;s personalized medicine strategy./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The Monogram purchase consideration has been allocated to the estimated fair market value of the net assets acquired, including approximately $63.5 in identifiable intangible assets (primarily non-tax deductible customer relationships, patents and technology, and trade name) with weighted-average useful lives of approximately 15 years;#160;#160;net operating loss tax assets of approximately $44.8, which are expected to be realized over a period of 18 years; and residual amount of non-tax deductible goodwill of approximately $83.6./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"#160;/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Monogram has an active research and development department, which is primarily focused on the development of companion diagnostics technology. As a result of this acquisition, the Company incurred approximately $5.2 of research and development expenses (included in selling, general and administrative expenses) for the year ended December 31, 2009./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In connection with the Monogram acquisition, the Company incurred approximately $2.7 in transaction fees and expenses (included in selling, general and administrative expenses)./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br //div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During the year ended December 31, 2008, the Company acquired various laboratories and related assets for approximately $203.9 in cash (net of cash acquired).#160;#160;These acquisitions were made primarily to extend the Company#8217;s geographic reach in important market areas or acquire scientific differentiation and esoteric testing capabilities./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Effective January 1, 2008 the Company acquired additional partnership units in its Ontario, Canada (#8220;Ontario#8221;) joint venture for approximately $140.9 in cash (net of cash acquired), bringing the Company#8217;s percentage interest owned to 85.6%. Concurrent with this acquisition, the terms of the joint venture#8217;s partnership agreement were amended. Based upon the amended terms of this agreement, the Company began including the consolidated operating results, financial position and cash flows of the Ontario joint venture in the Company#8217;s consolidated financial statements on January 1, 2008. The amended joint venture#8217;s partnership agreement also enables the holders of the noncontrolling interest to put the remaining partners hip units to the Company in defined future periods, at an initial amount equal to the consideration paid by the Company in 2008, and subject to adjustment based on market value formulas contained in the agreement. The initial difference of $123.0 between the value of the put and the underlying noncontrolling interest was recorded as additional noncontrolling interest liability and as a reduction to additional paid-in capital in the consolidated financial statements. The contractual value of the put, in excess of the current noncontrolling interest of $23.5, totals $118.9 at December 31, 2009./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;In December 2009, the Company received notification from the holders of the noncontrolling interest in the Ontario joint venture that they intend to put their remaining partnership units to the Company in accordance with the terms of the joint venture#8217;s partnership agreement. These units were acquired on February 8, 2010 for CN$147.8. On February 17, 2010, the Company completed a transaction to sell the units acquired from the previous noncontrolling interest holder to a new Canadian partner for the same price. Upon the completion of these two transactions, the Company#8217;s financial ownership percentage in the joint venture partnership remained unchanged at 85.6%. Concurrent with the sale to the new partner, the partnership agreement for the Ontario Canada joint venture was amended and restated with substantially the same terms as the previous agreement./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Net sales of the Ontario joint venture were $247.5 (CN$281.3) and $249.0 (CN$264.4) for the twelve months ended December 31, 2009 and 2008, respectively./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During the year ended December 31, 2007, the Company acquired various medical reference laboratories and related assets for approximately $222.3 in cash.#160;#160;These acquisitions were primarily done to extend the Company#8217;s geographic reach in important market areas or acquire scientific differentiation and esoteric testing capabilities./font/div

3. RESTRUCTURING AND OTHER SPECIAL CHARGES	12 Months Ended
3. RESTRUCTURING AND OTHER SPECIAL CHARGES	Dec. 31, 2009
Notes To Financial Statements [Abstract]
RESTRUCTURING AND OTHER SPECIAL CHARGES	div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"3. RESTRUCTURING AND OTHER SPECIAL CHARGES/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"#160;/div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During 2009, the Company recorded net restructuring charges of $13.5 primarily related to the closing of redundant and underutilized facilities. The majority of these costs related to severance and other employee costs and contractual obligations associated with leased facilities and other facility related costs. Of this amount, $10.5 related to severance and other employee costs for employees primarily in the affected facilities, and $12.5 related to contractual obligations associated with leased facilities and other facility related costs. The Company also reduced its prior restructuring accruals by $9.5, comprised of $7.3 of previously recorded facility costs and $2.2 of employee severance benefits as a result of incurring less cost than planned on those restructuring ini tiatives primarily resulting from favorable settlements on lease buyouts and severance payments that were not required to achieve the planned reduction in work force./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During 2008, the Company recorded net restructuring#160;charges of $32.4#160;primarily related to work force reductions and the closing of redundant and underutilized facilities. Of this amount, $20.9 related to severance and other employee costs in connection with the general work force reductions and $13.4 related to contractual obligations associated with leased facilities and equipment. The Company also /fontfont style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"recorded a credit of $1.9, comprised of $1.2 of previously recorded facility costs and $0.7 of employee severance benefits relating to changes in cost estimates accrued in prior periods./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During the third quarter of 2008, the Company also recorded a special charge of $5.5 related to estimated uncollectible amounts primarily owed by patients in the areas of the Gulf Coast severely impacted by hurricanes similar to losses incurred during the 2005 hurricane season./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During 2007, the Company recorded net restructuring#160;charges of $50.6 primarily#160;related to reductions in work force and consolidation of redundant and underutilized facilities. Of this amount, $24.8 related to employee severance benefits for employees primarily in management, administrative, technical, service and support functions and $19.4 related to contractual obligations and other costs associated with the closure of facilities. The charges also included a write-off of approximately $6.5 of accounts receivable balances remaining on a subsidiary#8217;s billing system that was abandoned during the year and $0.9 related to settlement of a preacquisition employment liability. The Company also recorded a credit of $1.0, comprised of $0.7 of previously r ecorded facility costs and $0.3 of employee severance benefits./font/div

PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Dec. 31, 2009	Dec. 31, 2008
Current assets:
Allowance for doubtful accounts	$ 173.1	$ 161.0
Shareholders' equity
Common stock, shares outstanding (in shares)	105.3	108.2

6. ACCOUNTS RECEIVABLE, NET	12 Months Ended
6. ACCOUNTS RECEIVABLE, NET	Dec. 31, 2009
Notes To Financial Statements [Abstract]
ACCOUNTS RECEIVABLE, NET	div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"6.#160;#160;ACCOUNTS RECEIVABLE, NET/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2009/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2008/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Gross accounts receivable/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"747.3/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"792.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Less allowance for doubtful accounts/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"(173.1/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap ="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt")/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"(161.0/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt")/font/td/tr tr bgcolor="#cceeff" td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"574.2/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"631.6/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;The provision for doubtful accounts was $248.9, $232.8 and $196.2 in 2009, 2008 and 2007 respectively. In addition, in the second quarter of 2008 the Company recorded a $45.0 increase in its provision for doubtful accounts. The Company#8217;s estimate of the allowance for doubtful accounts was increased due to the impact of the economy, higher patient deductibles and copayments, and acquisitions on the collectibility of accounts receivable balances./font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;During the third quarter of 2008, the Company also recorded a special charge of $5.5 related to estimated uncollectible amounts primarily owed by patients in the areas of the Gulf Coast severely impacted by hurricanes similar to losses incurred during the 2005 hurricane season./font/div

7. PROPERTY, PLANT AND EQUIPMENT, NET	12 Months Ended
7. PROPERTY, PLANT AND EQUIPMENT, NET	Dec. 31, 2009
Notes To Financial Statements [Abstract]
PROPERTY, PLANT, AND EQUIPMENT, NET	div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"7.#160;#160;#160;PROPERTY, PLANT AND EQUIPMENT, NET/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2009/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2008/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Land/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"23.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"20.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Buildings and building improvements/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"116.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"115.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Machinery and equipment/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"584.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"558.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Software/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"289.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"278.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Leasehold improvements/font/div /tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"147.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"127.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Furniture and fixtures/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"48.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"44.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Construction in progress/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"49.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"57.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Equipment under capital leases/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"3.5/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap" font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"3.5/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"1,263.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"1,206.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Less accumulated depreciation and amortization of capital lease assets/font/div /tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"(762.4/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt")/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-B OTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"(710.3/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt")/font/td/tr tr bgcolor="#cceeff" td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"500.8/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"496.4/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;Depreciation expense and amortization of capital lease assets was $130.7, $120.1 and $106.5 for 2009, 2008 and 2007, respectively, including software depreciation of $34.8, $33.7, and $34.8 for 2009, 2008 and 2007, respectively./font/div

9. ACCRUED EXPENSES AND OTHER	12 Months Ended
9. ACCRUED EXPENSES AND OTHER	Dec. 31, 2009
Notes To Financial Statements [Abstract]
ACCRUED EXPENSES AND OTHER	div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"9.#160;#160;ACCRUED EXPENSES AND OTHER/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2009/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2008/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr td valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Employee compensation and benefits/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"143.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"140.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Self-insurance reserves/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"56.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"48.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Accrued taxes payable/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"19.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"10.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Royalty and license fees payable/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"6.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"7.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Accrued repurchases of common stock/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"0.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Restructuring reserves/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"15.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"24.3/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Acquisition related reserves/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"5.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"8.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Interest payable/font/div /tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"8.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"8.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Other/font/div /tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"20.3/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font /tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"18.5/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"275.7/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PAD DING-BOTTOM: 4px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"266.4/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div

10. OTHER LIABILITIES	12 Months Ended
10. OTHER LIABILITIES	Dec. 31, 2009
Notes To Financial Statements [Abstract]
OTHER LIABILITIES	div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"10.#160;#160;OTHER LIABILITIES/font/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div div align="left"table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"December 31,/font/div /tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"/font#160;/div /tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2009/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"2008/font/div /tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr td valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Post-retirement benefit obligation/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"39.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"36.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Defined benefit plan obligation/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"41.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"94.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Restructuring reserves/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"10.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"9.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Self-insurance reserves/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"12.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"12.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Interest rate swap liability/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"10.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"13.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Acquisition related reserves/font/div/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"1.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"1.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td valign="bottom" width="76%" align="left" div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Deferred revenue/font/div /tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"22.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"6.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="white" td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"Other/font/div /tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"20.6/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font /tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"15.0/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr tr bgcolor="#cceeff" td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160; /font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"158.4/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="PAD DING-BOTTOM: 4px" valign="bottom" width="1%" align="left"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"189.6/font/tdtd style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"#160;/font/td/tr/table/div div style="TEXT-INDENT: 0pt; DISPLAY: block"br / /div